ECCB 2010 Next-gen sequencing Tutorial

-
Check out this SlideShare Presentation:
ECCB 2010 Next-gen sequencing Tutorial
View more presentations from Thomas Keane.

Comments

Post a Comment

Popular posts from this blog

Top 25 Indian Bioinformatics Companies

-
Here is another, quite interesting blog page with a list of Top 25 Indian Bioinformatics Companies by a fellow blogger Nabeel Basheer, while there is no actual criteria behind listing these 25 companies. It is a good handy list just in alphabetic order for all those job seekers. More so a good chronicle of the local informatics industry as well. 1. Accelrys Software Solution Pvt Ltd. 12th Floor, Discover, ITPL, White Field, Bangalore-65. www.accelrys.com 2. Apticraft Systems (P) Ltd. 142, Electronics Complex, Pardeshipura, Indore – 452010 (M.P.), India www.apticraft.com 3. Aptuit Informatics Plot No. 100-103, Export Promotion Industrial Park, White Field, Bangalore-560066 www.aptiuit.com 4. Bigtec J. K. Towers, 8th Block, Sangam Circle,46th Cross, Bangalore-560082. www.bigtec.org 5. Bijam Biosciences Private Limited Nagarjuna Hills, Hyderabad 500 082, India www.nagarjunagroup.com 6. Bio Base Databases India Pvt Ltd. Crescent Towers, 4th Floor, No : 32/1, Crescent Road, Bnagalore -...
Read more

Qiagen Provides Solutions for Swine Flu Surveillance

-
Qiagen has announced that two of its tests can be used to screen for the swine flu virus. Data analysis of the viral gene sequences showed that the artus Influenza LC RT PCR Kit and the Resplex II 2.0 Kit, can be used to detect whether or not Influenza A virus sequences are present in a sample, including the H1N1 subtype. If the sample proves positive, treatment with medication such as Tamiflu or Relenza can be prescribed, according to the recommendations given by the corresponding drug manufacturers. "We have compared the swine fever virus' sequence with our assays. The primers, which define the starting and end points of a genetic sequence that is amplified to make the target sequence visible, match 100 percent for the artus kit and almost 100 percent for the Resplex kit", said Dr Thomas Grewing, senior director, R&D. "We are now working closely with reference institutions to have both assays further re-validated and optimized based on clinical samples". B...
Read more